KHUSBU PATEL: Open Payments
NPI 1962107953 · LAWRENCEVILLE, GA. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$1,672 in 66 payments from 18 companies in 2025. Trend: 2023 $1,131 · 2024 $1,351 · 2025 $1,672
Food & beverage: $1,672
| Company | Payments | Amount |
|---|---|---|
| Amgen Inc. | 15 | $414 |
| Novo Nordisk Inc | 16 | $306 |
| Lilly USA, LLC | 6 | $184 |
| Sequel Med Tech, LLC | 2 | $183 |
| Ascendis Pharma Endocrinology Inc | 2 | $109 |
| Mannkind Corporation | 4 | $85 |
| SANOFI-AVENTIS U.S. LLC | 4 | $77 |
| ABBVIE INC. | 3 | $49 |
| Madrigal Pharmaceuticals | 2 | $41 |
| Xeris Pharmaceuticals, Inc. | 2 | $39 |
Products named: TEPEZZA, Ozempic, TWIIST, Yorvipath, Wegovy, AFREZZA, TZIELD, JARDIANCE.
Industry payments across GA — which companies pay providers there.
